A new quinolone, Factive, is coming on the market

September 2004

A new quinolone, Factive, is coming on the market.

Factive (gemifloxacin) is one of the "respiratory quinolones"... similar to Avelox (moxifloxacin), Levaquin (levofloxacin), and Tequin (gatifloxacin).

These quinolones are useful for respiratory infections... including pneumonia due to multi-drug resistant Strep pneumo.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

increased use of spironolactone for heart failure is causing more hospitalizations and deaths
Cholesterol a new combo tablet, Vytorin
Diabetes Liver function tests are now required less often for patients taking Actos (pioglitazone) or Avandia (rosiglitazone)
a new antidepressant, Cymbalta
Cardiology Does Altace (ramipril) improve survival after an MI better than other ACE inhibitors
Infectious Diseases The CDC is broadening the list of people who should get flu vaccine this year
Infectious Diseases A new quinolone, Factive, is coming on the market
Renal & Urology Sanctura, a new drug for overactive bladder
Renal & Urology nifedipine or tamsulosin (Flomax) to help expel SMALL kidney stones
Supplements Altovis, Red Bull, Umph, Amp, and other energy supplements
Women's Health increasing levothyroxine doses by one-third as soon as pregnancy is confirmed
Women's Health pros and cons of soy for postmenopausal women
Neurology & Pain how to switch opioids

A new quinolone, Factive, is coming on the market

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Table of Contents